STOK
Stoke Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.82
+2.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 54.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.63x
- Price / sales
- 58.05x
- Price / cash flow
- -9.00x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 47.54x
- EV / EBITDA
- -6.33x
- EV / EBIT
- -5.87x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026